Adjusted-dose warfarin versus aspirin for preventing stroke in patients with atrial fibrillation

Annals of Internal Medicine

Volumn 147, Issue 8, 2007, Pages 590-592

  Hart, Robert G ^a   Pearce, Lesly A ^b   Aguilar, Maria I ^c  

^a UNIVERSITY OF TEXAS HEALTH SCIENCE CENTER AT SAN ANTONIO   (United States)

^b Mayo Clinic Scottsdale ^*

^c MAYO CLINIC   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ACETYLSALICYLIC ACID; WARFARIN; ANTICOAGULANT AGENT; FIBRINOLYTIC AGENT;

AGED; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; DRUG EFFICACY; DRUG SAFETY; HEART ATRIUM FIBRILLATION; HUMAN; INTERNATIONAL NORMALIZED RATIO; LETTER; META ANALYSIS; PRIMARY PREVENTION; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; RISK REDUCTION; SECONDARY PREVENTION; STROKE; SYSTEMATIC REVIEW; TRANSIENT ISCHEMIC ATTACK; UNITED KINGDOM; CEREBROVASCULAR ACCIDENT;

AGED; AGED, 80 AND OVER; ANTICOAGULANTS; ASPIRIN; ATRIAL FIBRILLATION; CEREBROVASCULAR ACCIDENT; FIBRINOLYTIC AGENTS; HUMANS; WARFARIN;

EID: 35848965028     PISSN: 00034819     EISSN: None     Source Type: Journal    
DOI: 10.7326/0003-4819-147-8-200710160-00018     Document Type: Letter

References (14)